Guardant Health (GH) Receivables (2017 - 2026)

Guardant Health has reported Receivables for 10 years, with the latest figure at $144.2 million in Q2 2026.

• Quarterly Receivables rose 10.75% year-over-year to $144.2 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $144.2 million (up 10.75% YoY) and the FY2025 annual result came in at $137.8 million, up 25.03% from the prior year.
• Receivables climbed to $144.2 million in Q2 2026 per GH's latest filing, from $137.4 million in the prior quarter.
• Over five years, Receivables peaked at $144.2 million in Q2 2026 and troughed at $3.4 million in Q4 2024.
• A 5-year average of $98.4 million and a median of $92.0 million in 2022 frame the typical range for Receivables.
• The sharpest annual moves came in 2024 and 2025: Receivables sank 96.17% in 2024, then soared 3954.38% in 2025.
• Over 5 years, Receivables stood at $97.3 million in 2022, then declined by 8.71% to $88.8 million in 2023, then tumbled by 96.17% to $3.4 million in 2024, then jumped by 3954.38% to $137.8 million in 2025, then gained by 4.64% to $144.2 million in 2026.
• According to Business Quant data, Receivables over the past three periods registered $144.2 million, $137.4 million, and $137.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.